Comment on Rivas et al. Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil. Cancers 2025, 17, 2683
As the executive leadership of the Collaborative Ocular Oncology Group (COOG), which has conducted the largest prospective clinical studies ever performed in patients with uveal melanoma, we read with concern the recent report by Rivas, Samlowski and McCannel, which claims that brachytherapy combined with vitrectomy and silicone oil injection results in an "unexpectedly low rate" of metastasis and death in patients with uveal melanoma [...].
Authors
- Miguel A. Materin (ORCID: https://orcid.org/0000-0001-9097-9512)
- Amy C Schefler (ORCID: https://orcid.org/0000-0001-9829-8164)
- Alison H. Skalet (ORCID: https://orcid.org/0000-0002-4690-7957)
- Zélia M. Corrêa (ORCID: https://orcid.org/0000-0003-2946-3757)
- Brian P. Marr (ORCID: https://orcid.org/0000-0002-0208-9665)
- David A. Reichstein (ORCID: https://orcid.org/0000-0003-2673-876X)
- J. William Harbour (ORCID: https://orcid.org/0000-0002-1104-9809)
- Prithvi Mruthyunjaya
Institutions
- University of Miami (US)
- Oregon Health & Science University (US)
- Duke University (US)
- Retina Consultants of Texas (US)
- Tennessee Retina (US)
- Columbia University (US)
- The University of Texas Southwestern Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- Cancers
- Published
- 2026-04-10
- DOI
- https://doi.org/10.3390/cancers18081208
- Citations
- 1
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 25.16